Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes

NCT00383578 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

335

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Vildagliptin 100 mg qd
DRUG: Metformin 1500 mg daily

Sponsor

Novartis Pharmaceuticals